This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Inventia Healthcare Private Limited. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maharashtra, IN (2016)
- Thane, IN (2019)
Company Filing History:
Years Active: 2016-2019
Title: Sunil Deviprasad Tiwari: Innovator in Pharmaceutical Compositions
Introduction
Sunil Deviprasad Tiwari is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release compositions. With a total of 3 patents to his name, Tiwari's work is focused on improving drug delivery systems.
Latest Patents
Tiwari's latest patents include innovative extended release pharmaceutical compositions. These compositions are structured for once-a-day administration and comprise skeletal muscle relaxants such as cyclobenzaprine or its pharmaceutically acceptable salts. The invention ensures that the drug's release is extended under in-vitro conditions for at least 8 to 12 hours. Additionally, the patent outlines the process for preparing such structured compositions, showcasing Tiwari's commitment to enhancing therapeutic efficacy.
Career Highlights
Sunil Deviprasad Tiwari is associated with Inventia Healthcare Private Limited, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in drug formulation and delivery, making a positive impact on patient care.
Collaborations
Tiwari collaborates with talented professionals in his field, including Sunil Beharilal Jaiswal and Vaibhavi Shah. These collaborations foster a creative environment that drives innovation and enhances the quality of their work.
Conclusion
Sunil Deviprasad Tiwari is a distinguished inventor whose contributions to pharmaceutical compositions are noteworthy. His innovative approach to drug delivery systems continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile